You are here

  • Home
  • Archive
  • Volume 9, Issue 6
  • Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis

Article metrics

Article menu

This article has a correction. Please see:

XML
Clinical/translational cancer immunotherapy
Original research
Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis

 

Online download statistics by month:

Online download statistics by month: June 2021 to August 2025

AbstractFullPdf
Jun 2021256257107
Jul 2021269273103
Aug 202112812839
Sep 202116416469
Oct 202114914968
Nov 202111011241
Dec 202110310519
Jan 202234035462
Feb 202248751179
Mar 202213213346
Apr 202211512447
May 2022949751
Jun 20229810732
Jul 2022858530
Aug 202211211949
Sep 202211611646
Oct 2022666923
Nov 2022919226
Dec 2022939435
Jan 2023787928
Feb 202311611619
Mar 2023636533
Apr 2023505315
May 2023727224
Jun 2023777723
Jul 2023646423
Aug 2023737430
Sep 2023383824
Oct 2023545421
Nov 2023545621
Dec 2023474717
Jan 2024495026
Feb 2024292914
Mar 2024626269
Apr 2024626632
May 2024495025
Jun 2024767525
Jul 2024939529
Aug 2024555428
Sep 2024484916
Oct 2024656533
Nov 2024636535
Dec 2024838423
Jan 2025757525
Feb 2025666632
Mar 2025999926
Apr 2025969628
May 2025869052
Jun 2025484926
Jul 2025110
Aug 2025330
Total500251071794